Skip to main content
. Author manuscript; available in PMC: 2021 Nov 17.
Published in final edited form as: Ann Vasc Surg. 2021 Jun 25;76:232–243. doi: 10.1016/j.avsg.2021.04.045

Table III.

Comparison of AKI and non-AKI patients

Characteristics AKI (n = 22) Non-AKI (n = 117) P value

Age 69.47 (6.65) 71.44 (8.79) 0.2354
Male 13 (59.1) 77 (65.8) 0.5449
Congestive Heart Failure 4 (18.2) 31 (26.5) 0.5932
Hypertension 19 (86.4) 104 (88.9) 0.7193
Smoking 22 (100.0) 101 (86.3) 0.0752
COPD 10 (45.5) 56 (47.9) 1.0000
Diabetes 4 (18.2) 22 (18.8) 1.0000
History of Stroke 4 (18.2) 33 (28.2) 0.4346
Baseline eGFR 65.50 [58.25, 81.50] 63.00 [52.00, 85.00] 0.6348
Baseline Creatinine 0.92 [0.82, 1.24] 1.06 [0.83, 1.24] 0.5199
Baseline CKD Stage 3/4/5 3 (13.6) 21 (17.9) 0.7658
Symptomatic 8 (36.4) 36 (30.8) 0.6229
Active or Contained Rupture 1 (4.5) 4 (3.4) 0.5833
Aortic Angulation
 Thoracic 48.45 [22.50, 73.38] 30.00 [15.00, 52.10] 0.0654
 Diaphragm 42.70 [25.75, 100.00] 30.00 [20.00, 36.67] 0.0227
 Renal 31.35 [16.25, 77.50] 20.90 [11.00, 38.83] 0.0951
Hemoglobin < 7 4 (18.2) 8 (6.8) 0.0984
ASA Score III/IV/V 22 (100.0) 117 (100.0) NA
Contrast Volume (mL) 78.00 [54.75, 173.50] 91.00 [57.00, 140.00] 0.9563
Intervention Time (min) 398.50 [275.25, 511.00] 254.00 [197.00, 375.00] 0.0023
Fluoroscopy Time (min) 117.00 [87.30, 157.30] 77.10 [65.40, 108.70] 0.0041
Accessory renal sacrifice 1 (6.7) 8 (8.2) 1.0000
Aneurysm type 0.2655
 Crawford I-III Aneurysm 13 (59.1) 43 (36.8)
 Crawford IV Aneurysm 6 (27.3) 33 (28.2)
 Crawford V Aneurysm 0 (0.0) 2 (1.7)
 Para/juxtarenal Aneurysm 3 (13.6) 28 (23.9)
Retrograde Type B Aortic Dissection 0 (0.0) 11 (9.4)

CKD, Chronic Kidney Disease; COPD, Chronic Obstructive Pulmonary Disease.

Categorical variables are presented as number (%). Continuous variables are presented as mean (standard deviation) or median [interquartile range].